INSIGHTS ON PHARMACEUTICAL PACKAGING
-
Vial Breakage During Lyophilization: Root Causes And Mitigation
Learn how controlling freezing rates, using specialized vials, and employing optimized stoppering techniques can reduce the risk of vial breakage during lyophilization and ensure high product quality.
-
Key Considerations When Choosing A Device For Dry Powder Nasal Delivery
Building on previous discussions, here we discuss the benefits of nasal delivery and the challenges of developing dry powder formulations by focusing on key devices that can be used for delivering dry powder nasal dosage forms.
-
Navigating Regulatory Expectations For Injectable Packaging
Explore insights on extractables, focusing on how they relate to the revised EU GMP Annex 1, new and evolved expectations under USP <382>, and the use of VHP decontamination in aseptic environments.
-
Overcome Common Pre-Filled Syringe Challenges Through Partnership
The pre-filled syringe space is one of the fastest growing pharma sectors, offering greater patient safety and lower manufacturing costs. But pre-filled doesn’t translate to easily filled; there are particular obstacles to overcome.
-
The Rising Need For Flexibility In Blister Packaging For CDMOs And Drug Manufacturers8/1/2024
In the pharmaceutical industry, processes are subject to continuous change due to evolving requirements and regulations. Consequently, pharmaceutical companies and contract packagers often require adaptable packaging solutions, such as blister machines, to meet these dynamic needs.
-
Importance Of Assessing Mannitol Crystallinity In Lyophilized Drug Products10/16/2024
Drug product stability may be seriously compromised if mannitol completes crystallization during storage rather than during the freezing or annealing step in the lyophilization process.
-
Future Of Pharma Packaging: Trends, Tech, And Patient Solutions9/25/2025
Explore how traditional and innovative pharmaceutical packaging formats improve patient adherence, support emerging therapies, and shape the future of drug delivery and treatment outcomes.
-
Meeting Annex 1: A Proactive Approach To Regulatory Compliance3/4/2025
It was imperative for a large European CMO that produces multiple biologic drugs to select the right product quality and value for each customer to comply with the August 2023 revision to the EU GMP Annex 1.
-
Key Considerations When Developing Your Combination Product2/20/2024
Succeed in combination product development by understanding the risk factors that may arise and implementing mitigation strategies that will streamline the device development process.
PHARMACEUTICAL PACKAGING SOLUTIONS
-
With its horizontal form, fill, and seal technology, Körber presents a packaging machine that is designed for quick changeover of flexible and rigid blisters and can be individually adapted to future format changes, re-tools, and web width changes. In addition, our Thermoformer machines can be rapidly and easily retrofitted for new processes. Fully automated loading and packaging systems integrate seamlessly for an instant upgrade.
-
A generic drug must contain the same active ingredients as the original formulation. According to the U.S. Food and Drug Administration (FDA), generic drugs are identical or within an acceptable bioequivalent range to the brand-name counterpart with respect to pharmacokinetic and pharmacodynamic properties.
-
When off-the-shelf products fall short, specialized custom manufacturing can provide the specific material concentrations, packaging, and handling capabilities your life science process requires.
-
Backed by Pfizer’s resources, we seek to treat your products as if they are our own, giving you access to the same expertise and state-of-the-art technologies that Pfizer uses to deliver its breakthroughs.
-
We are the exclusive manufacturing partner for this innovative auto-injector platform.